Back
Candel Therapeutics 10K Form
Buy
90
CADL
Candel Therapeutics
Last Price:
10.16
Seasonality Move:
2.61%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CADL News And Ratings
See the #1 stock for the next 7 days that we like better than CADL
CADL Financial Statistics
Sales & Book Value
| Annual Sales: | $125K |
|---|---|
| Cash Flow: | $-6.57M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.47 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -1.73000 |
|---|---|
| Net Income (TTM): | $-52.2M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Candel Therapeutics Earnings Forecast
Key Candel Therapeutics Financial Ratios
- The Interest Expense is -6.84% of Operating Income.
- Per Share Earnings over the last 5 years have been positive in 1 years.
Candel Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CADL |
| Website: | candeltx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CADL Technical Analysis vs Fundamental Analysis
Buy
90
Candel Therapeutics (CADL)
is a Buy
Is Candel Therapeutics a Buy or a Sell?
-
Candel Therapeutics stock is rated a Buy
The current Candel Therapeutics [CADL] share price is $9.80. The Score for CADL is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.